Salona Global Medical Device Corporation Provides Guidance; Publishes Call Transcript

SAN DIEGO, Dec. 09, 2021 (GLOBE NEWSWIRE) — Salona Global Medical Device Corporation (“Salona” or the “Company”) (TSXV:SGMD), an acquisition-oriented medical device company serving the global injury and surgery recovery (known as recovery science) market, is pleased to provide guidance on the Company’s performance. The Company expects to build significantly on its published annual revenue run-rate of $24 million per year announced September 30, 2021 by year end. Through a combination of organic growth and closing at least one more acquisition, management anticipates generating annual run-rate revenues of $40 million, with estimated gross margins of approximately 30-40%, by fiscal year end (February 28, 2022). Read More